Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Non-cash Items (2011 - 2025)

Lemaitre Vascular (LMAT) reported Non-cash Items of $13.6 million for Q4 2025, up 3791.35% year-over-year from $349981.0 in Q4 2024, and up 3791.35% on a QoQ basis from $349981.0 in Q4 2024.

Lemaitre Vascular (LMAT) has 15 years of Non-cash Items data on file, last reported at $13.6 million in Q4 2025.

  • Quarterly Non-cash Items rose 3791.35% year-over-year to $13.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.6 million (up 3791.35% YoY) and the FY2025 annual result came in at $13.6 million, up 3791.35% from the prior year.
  • Non-cash Items rose to $13.6 million in Q4 2025 per LMAT's latest filing, from $349981.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $13.9 million in Q4 2021 and bottomed at $349981.0 in Q4 2024.
  • The 5-year median for Non-cash Items is $10.9 million (2023), against an average of $9.3 million.
  • The widest annual swing landed in 2024, when Non-cash Items tumbled 96.8%; it then soared 3791.35% in 2025.
  • Tracing LMAT's Non-cash Items over 5 years: stood at $13.9 million in 2021, then plunged by 43.27% to $7.9 million in 2022, then surged by 38.66% to $10.9 million in 2023, then plunged by 96.8% to $349981.0 in 2024, then soared by 3791.35% to $13.6 million in 2025.
  • Per Business Quant, the three latest LMAT Non-cash Items figures stand at $13.6 million (Q4 2025), $349981.0 (Q4 2024), and $10.9 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Lemaitre Vascular 2.28 Bn 1.91 Bn 48.40 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 13.62 Mn
Dec 31, 2025 13.62 Mn
Dec 31, 2024 349,981.00
Dec 31, 2024 349,981.00
Dec 31, 2023 10.92 Mn
Dec 31, 2023 10.92 Mn
Dec 31, 2022 7.88 Mn
Dec 31, 2022 7.88 Mn
Dec 31, 2021 13.89 Mn
Dec 31, 2021 13.89 Mn
Dec 31, 2020 13.89 Mn
Dec 31, 2020 13.89 Mn
Dec 31, 2019 11.44 Mn
Dec 31, 2019 11.44 Mn
Dec 31, 2018 12.21 Mn
Dec 31, 2018 12.21 Mn
Dec 31, 2017 27.77 Mn
Dec 31, 2017 27.77 Mn
Dec 31, 2016 29.87 Mn
Dec 31, 2016 29.87 Mn
Dec 31, 2015 15.38 Mn
Dec 31, 2015 15.38 Mn
Dec 31, 2014 3.77 Mn
Dec 31, 2014 3.77 Mn
Dec 31, 2013 4.82 Mn
Dec 31, 2013 4.82 Mn
Dec 31, 2012 2.15 Mn
Dec 31, 2012 2.15 Mn
Dec 31, 2011 3.06 Bn
Dec 31, 2011 3.06 Bn